Provided is a humanized or chimeric antibody or fragment thereof capable of binding to interleukin-10 (IL-10) wherein said antibody or fragment thereof is capable of being administered to a subject in the absence of an intolerable increase in the level of pro- inflammatory cytokines. Further provided are methods of treatment involving the use of the antibody or fragment thereof.